rawfin.tv
Clearmind Medicine Responds to HHS RFI on Alcohol Use Disorder Treatment
RegulationstocksAI Generated

Clearmind Medicine Responds to HHS RFI on Alcohol Use Disorder Treatment

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Clearmind Medicine Inc. has submitted a formal response to a U.S. Department of Health and Human Services Request for Information. The response highlights its MEAI-based CMND-100 as a potential treatment for alcohol use disorder.

biotechdrug developmentHHSalcohol use disorderpharmaceuticals

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks